Chee Conley
Syros Pharmaceuticals, Inc. · President & CEO
Chee Conley is listed in filings as President & CEO at Syros Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Nov 20, 2024, including sale activity and purchase activity. Recent filings connect the profile to Syros Pharmaceuticals, Inc. (SYRS). The current snapshot covers public activity from Sep 12, 2024 to Nov 20, 2024. Reported amounts are shown as $26.9K to $85.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $85k50k shares | BuySep 11, 2024 | $1.71 | $0.0002 | |
| $75k50k shares | BuySep 10, 2024 | $1.51 | $0.0002 |